Literature DB >> 9060624

Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization.

T M Fu1, A Friedman, J B Ulmer, M A Liu, J J Donnelly.   

Abstract

DNA immunization offers a novel means to induce cellular immunity in a population with a heterogeneous genetic background. An immunorecessive cytotoxic T-lymphocyte (CTL) epitope in influenza virus nucleoprotein (NP), residues 218 to 226, was identified when mice were immunized with a plasmid DNA encoding a full-length mutant NP in which the anchor residues for the immunodominant NP147-155 epitope were altered. Mice immunized with wild-type or mutant NP DNA were protected from lethal cross-strain virus challenge, and the protection could be adoptively transferred by immune splenocytes, indicating the role of cell-mediated immunity in the protection. DNA immunization is capable of eliciting protective cellular immunity against both immunodominant and immunorecessive CTL epitopes in the hierarchy seen with virus infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9060624      PMCID: PMC191393     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis.

Authors:  E R Christinck; M A Luscher; B H Barber; D B Williams
Journal:  Nature       Date:  1991-07-04       Impact factor: 49.962

2.  Do L3T4+ T cells act as effector cells in protection against influenza virus infection.

Authors:  S Lightman; S Cobbold; H Waldmann; B A Askonas
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

3.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules.

Authors:  K Falk; O Rötzschke; S Stevanović; G Jung; H G Rammensee
Journal:  Nature       Date:  1991-05-23       Impact factor: 49.962

4.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

Authors:  A R Townsend; J Rothbard; F M Gotch; G Bahadur; D Wraith; A J McMichael
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

Review 5.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

6.  The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

7.  Identification and characterization of T helper epitopes in the nucleoprotein of influenza A virus.

Authors:  X M Gao; F Y Liew; J P Tite
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

8.  Immunogenicity and protective efficacy of a tuberculosis DNA vaccine.

Authors:  K Huygen; J Content; O Denis; D L Montgomery; A M Yawman; R R Deck; C M DeWitt; I M Orme; S Baldwin; C D'Souza; A Drowart; E Lozes; P Vandenbussche; J P Van Vooren; M A Liu; J B Ulmer
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

9.  Cytotoxic T-cell immunity to influenza.

Authors:  A J McMichael; F M Gotch; G R Noble; P A Beare
Journal:  N Engl J Med       Date:  1983-07-07       Impact factor: 91.245

10.  Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells.

Authors:  M Eichelberger; W Allan; M Zijlstra; R Jaenisch; P C Doherty
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  31 in total

1.  Experimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65).

Authors:  R Holtappels; J Podlech; N K Grzimek; D Thomas; M F Pahl-Seibert; M J Reddehase
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8(+) T-cell memory.

Authors:  J P Christensen; P C Doherty; K C Branum; J M Riberdy
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Vaccination with cell immunoglobulin mucin-1 antibodies and inactivated influenza enhances vaccine-specific lymphocyte proliferation, interferon-gamma production and cross-strain reactivity.

Authors:  W Soo Hoo; E R Jensen; A Saadat; D Nieto; R B Moss; D J Carlo; T Moll
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

4.  Structural engineering of pMHC reagents for T cell vaccines and diagnostics.

Authors:  Vesselin Mitaksov; Steven M Truscott; Lonnie Lybarger; Janet M Connolly; Ted H Hansen; Daved H Fremont
Journal:  Chem Biol       Date:  2007-08

5.  Location of antigenic sites recognized by monoclonal antibodies in the influenza A virus nucleoprotein molecule.

Authors:  Natalia L Varich; Konstantin S Kochergin-Nikitsky; Evgeny V Usachev; Olga V Usacheva; Alexei G Prilipov; Robert G Webster; Nikolai V Kaverin
Journal:  J Gen Virol       Date:  2009-03-18       Impact factor: 3.891

6.  Memory CD8+ T cells specific for a single immunodominant or subdominant determinant induced by peptide-dendritic cell immunization protect from an acute lethal viral disease.

Authors:  Sanda Remakus; Daniel Rubio; Xueying Ma; Alessandro Sette; Luis J Sigal
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

7.  Increased humoral immunity by DNA vaccination using an α-tocopherol-based adjuvant.

Authors:  Ingrid Karlsson; Marie Borggren; Jens Nielsen; Dennis Christensen; Jim Williams; Anders Fomsgaard
Journal:  Hum Vaccin Immunother       Date:  2017-06-14       Impact factor: 3.452

8.  Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA.

Authors:  J B Ulmer; T M Fu; R R Deck; A Friedman; L Guan; C DeWitt; X Liu; S Wang; M A Liu; J J Donnelly; M J Caulfield
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 9.  Genetic vaccines: strategies for optimization.

Authors:  G Gregoriadis
Journal:  Pharm Res       Date:  1998-05       Impact factor: 4.200

10.  Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope.

Authors:  Hoyin Mok; Sujin Lee; David W Wright; James E Crowe
Journal:  Vaccine       Date:  2008-07-26       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.